ERBB2 and breast cancer: To determine the potential impact of membrane ICOSL expression on patient survival, the Kaplan–Meier (K–M) procedure was applied according to different types of breast cancers such as Luminal A/B, HER2 positive and triple negative breast cancer (TNBC).